Aytu Biopharma (AYTU) Asset Utilization Ratio (2013 - 2026)
Aytu Biopharma (AYTU) posted quarterly Asset Utilization Ratio of 0.48 for Q1 2026, down 11.56% year-over-year from 0.55 in Q1 2025, and down 4.5% quarter-over-quarter from 0.51 in Q4 2025.
Aytu Biopharma (AYTU) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Asset Utilization Ratio for 14 consecutive years, with 0.48 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 11.56% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (down 11.56% YoY), while the FY2025 annual figure was 0.55, up 7.0% from the prior year.
- Asset Utilization Ratio eased to 0.48 in Q1 2026 per AYTU's latest filing, from 0.51 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.76 in Q2 2023 and bottomed at 0.47 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.6 across 5 years, with a median of 0.55 in 2025.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 137.29% — and 2024, when it plunged 30.28%.
- Aytu Biopharma's Asset Utilization Ratio stood at 0.72 in 2022, then decreased by 5.92% to 0.68 in 2023, then declined by 22.36% to 0.53 in 2024, then fell by 4.17% to 0.51 in 2025, then slipped by 4.5% to 0.48 in 2026.
- Business Quant data shows AYTU's Asset Utilization Ratio at 0.48 in Q1 2026, 0.51 in Q4 2025, and 0.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | 0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.51 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.53 |
| Mar 31, 2025 | 0.55 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.63 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.72 |
| Jun 30, 2023 | 0.76 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.72 |
| Sep 30, 2022 | 0.71 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | 0.47 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | 0.50 |